Harbour BioMed wins landmark US patent victory against Amgen reshaping antibody landscape
June 15, 2026 | 09:06
Harbour BioMed has secured a landmark victory in a U.S. patent infringement case against Amgen, a ruling described as reshaping the global antibody patent landscape for the biopharmaceutical industry.
Latest News
Mobile Version